Bozitinib (PLB-1001)

Ask supplier a question | View on supplier's website

Bozitinib (PLB-1001, CBT-101, APL-101, CBI-3103) is a highly selective ATP-competitive c-Met inhibitor with blood-brain barrier permeability. Bozitinib (PLB-1001) selectively inhibits MET-altered tumor cells in preclinical models.

Supplier	Selleck Chemicals
Product #	S6762
Sku #	S6762-2mg
Pricing	2mg, $179.00

Feedback